325 related articles for article (PubMed ID: 31240326)
21. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
22. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
24. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.
Hong AM; Ferguson P; Dodds T; Jones D; Li M; Yang J; Scolyer RA
Oral Oncol; 2019 May; 92():33-39. PubMed ID: 31010620
[TBL] [Abstract][Full Text] [Related]
25. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
26. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer.
McIlwain WR; Sood AJ; Nguyen SA; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 May; 140(5):441-7. PubMed ID: 24652023
[TBL] [Abstract][Full Text] [Related]
27. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
Biron VL; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
[TBL] [Abstract][Full Text] [Related]
28. Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma.
Broglie MA; Jochum W; Förbs D; Schönegg R; Stoeckli SJ
Cancer Cytopathol; 2015 Dec; 123(12):732-8. PubMed ID: 26348982
[TBL] [Abstract][Full Text] [Related]
29. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
[TBL] [Abstract][Full Text] [Related]
30. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.
Hama T; Tokumaru Y; Fujii M; Yane K; Okami K; Kato K; Masuda M; Mineta H; Nakashima T; Sugasawa M; Sakihama N; Yoshizaki T; Hanazawa T; Kato H; Hirano S; Imanishi Y; Kuratomi Y; Otsuki N; Ota I; Sugimoto T; Suzuki S
Oncology; 2014; 87(3):173-82. PubMed ID: 25033838
[TBL] [Abstract][Full Text] [Related]
33. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
[TBL] [Abstract][Full Text] [Related]
34. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
Wang MB; Liu IY; Gornbein JA; Nguyen CT
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
[TBL] [Abstract][Full Text] [Related]
35. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
36. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
[TBL] [Abstract][Full Text] [Related]
38. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
39. Comparing serum protein levels can aid in differentiating HPV-negative and -positive oropharyngeal squamous cell carcinoma patients.
Dickinson A; Saraswat M; Syrjänen S; Tohmola T; Silén R; Randén-Brady R; Carpén T; Hagström J; Haglund C; Mattila P; Mäkitie A; Joenväärä S; Silén S
PLoS One; 2020; 15(6):e0233974. PubMed ID: 32542012
[TBL] [Abstract][Full Text] [Related]
40. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.
Martin-Gomez L; Fulp WJ; Schell MJ; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Lorincz A; Wenig B; Chung CH; Caudell JJ; Giuliano AR
Oral Oncol; 2019 May; 92():85-91. PubMed ID: 31010629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]